mafosfamide has been researched along with Leukopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Futami, H; Jansen, R; Keller, J; Longo, DL; MacPhee, MJ; McCormick, K; Oppenheim, JJ; Ruscetti, FW; Wiltrout, RH | 1 |
Mittendorff, F; Wagner, T; Walter, E | 1 |
2 other study(ies) available for mafosfamide and Leukopenia
Article | Year |
---|---|
Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
Topics: Animals; Carcinoma; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; In Vitro Techniques; Interleukin-1; Kidney Neoplasms; Leukopenia; Lung; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Recombinant Proteins; Survival Analysis; Tumor Cells, Cultured | 1990 |
Intracavitary chemotherapy with activated cyclophosphamides and simultaneous systemic detoxification with protector thiols in Sarcoma 180 ascites tumor.
Topics: Animals; Biological Availability; Cyclophosphamide; Cysteine; Female; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Leukopenia; Mice; Sarcoma 180 | 1986 |